Search results
Fredericksburg doctor convicted in federal court for $70 million Medicare fraud scheme
Gannett via AOL· 53 minutes agoA federal jury convicted a Fredericksburg doctor on Friday for a $70 million Medicare fraud scheme in which he signed thousands of prescriptions for braces and genetic tests that he said were ...
New Research Demonstrates the Importance of Genetic Testing for Many Cancers Not Currently Covered...
NBC 10 - FOX 14 Monroe· 23 hours agoInvitae (OTC:NVTAQ), a leading medical genetics company, today announced eight studies to be presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago ...
Many people quit new weight-loss drugs because of costs, side effects
UPI· 13 hours agoReasons for quitting Wegovy, Ozempic or similar drugs may include cost or gastrointestinal side...
Genetic test may tell who will benefit most from injected weight-loss medications
UPI· 3 days agoResearch shows that a new test that assigns a genetic risk score to patients may be able to spot who...
Genetic Test Can Predict Response to Semaglutide
Medscape· 4 days agoWith an assist from machine learning, investigators find a genetic test that can identify obesity phenotypes and predict who will benefit most from...
Fulgent Announces Second Drug in Development and New Prenatal Genetic Test
Los Angeles Business Journal· 4 days agoEl Monte-based genetic testing and analysis company Fulgent Genetics Inc., which rode the Covid...
23andMe Fiscal Q4 Revenues Drop 31 Percent as Research Services,Genetic Test Kit Sales Shrink
GenomeWeb News· 22 hours agoNEW YORK – 23andMe reported after the close of market Thursday a year-over-year revenue loss of 31 percent for its fiscal 2024 fourth quarter and a decrease of 27 percent for the full year.
'Hungry gut' gene marker may help determine who will benefit the most from weight loss drugs
MedicalNewsToday via AOL· 4 days agoResearchers say a genetic test that can help identify a "hungry gut" phenotype can help determine...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 22 hours agoSALT LAKE CITY, May 23, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, and its collaborators will share data from seven studies at the 2024 ASCO Annual Meeting. Three studies
Genetic test could reveal weight loss potential of Ozempic, Wegovy
Becker’s Hospital Review· 5 days agoA $350 genetic test developed by researchers at Mayo Clinic in Rochester, Minn., and subsequently licensed to Phenomic Sciences, seeks to assign risk scores ...